$IBIO Don’t sleep on IBiO-202 folks. We are currently in enabling challenge studies with hopes of clinical trials by the end of the year. Could be sooner. Who knows? They certainly are still convinced of the need for a second gen Covid vaccine, specifically one focusing on the brain of the virus, the N protein. Also, feasibility studies for the micro array patch system should be anytime. This venture fascinates me. I’m not sure what would have to happen for me to lose confidence in this ticker. I’m sold on all phases of this company. If I liquidated my position I would be violating my own conscience. The future of medicine is in plants, and we are ground floor here!